RecruitingNCT06462430

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

Studying PTEN hamartoma tumor syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Yale University
Principal Investigator: Hande Kaymakcalan Celebiler, MD
Yale University
Enrollment: 100 enrolled
Eligibility: 1 years · All sexes
Timeline: 2022 – 2026

Study locations (1)

Dr.Canan Kocaman pediatric clinic, Istanbul, Turkey (Türkiye)

Collaborators

Boston Children's Hospital · Ege University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06462430 on ClinicalTrials.gov

Other trials for PTEN hamartoma tumor syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06805734
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

See all trials for PTEN hamartoma tumor syndrome →

← Back to all trials